| JABAX | RLBEX | JABAX / RLBEX | |
| Total Expense Ratio | 0.82 | 0.59 | 139% |
| Annual Report Gross Expense Ratio | 0.82 | 0.59 | 139% |
| Fund Existence | 33 years | 23 years | - |
| Gain YTD | 12.881 | 14.042 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 28.5B | 263B | 11% |
| Annual Yield % from dividends | 1.58 | 1.71 | 92% |
| Returns for 1 year | 7.27 | 8.98 | 81% |
| Returns for 3 years | 40.37 | 41.02 | 98% |
| Returns for 5 years | 36.85 | 38.72 | 95% |
| Returns for 10 years | 93.83 | 73.32 | 128% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HELX | 35.66 | 0.67 | +1.92% |
| Franklin Genomic Advancements ETF | |||
| PJFG | 109.24 | 0.76 | +0.70% |
| PGIM Jennison Focused Growth ETF | |||
| SPYI | 51.67 | 0.19 | +0.36% |
| NEOS S&P 500(R) High Income ETF | |||
| SEPU | 28.37 | 0.05 | +0.19% |
| AllianzIM U.S. Equity Buffer15 UncSepETF | |||
| RPAR | 21.25 | -0.02 | -0.11% |
| RPAR Risk Parity ETF | |||